GRI Bio
GRI
NASDAQ
IPO2023
about GRI
GRI Bio is a biotechnology company focused on advancing innovative solutions in gene editing and cell therapy to address unmet medical needs.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $6.21 | $6.70 | $3.87 | $2.85M | 12.40M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$1.28 | n/a | n/a | 0% | 0% | 0% |